Meridian Bioscience (VIVO) Tops Q2 EPS by 8c, Offers Guidance

May 7, 2021 7:40 AM EDT
Get Alerts VIVO Hot Sheet
Price: $20.39 -2.81%

Financial Fact:
Research and development: 3.76M

Today's EPS Names:
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.56, $0.08 better than the analyst estimate of $0.48. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $84.5 million.


Meridian Bioscience sees FY2021 EPS of $1.60-$1.80, versus the consensus of $1.66. Meridian Bioscience sees FY2021 revenue of $305-335 million, versus the consensus of $324 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities